Skip to main content
SpringerLink
Log in

Roles of Gut Hormones in the Regulation of Food Intake and Body Weight

  • Reference work entry
  • First Online:
Obesity

Part of the book series: Endocrinology ((ENDOCR))

  • 1783 Accesses

Abstract

The gastrointestinal tract is extremely rich in endocrine cells and secretes a myriad of hormones, including ghrelin, glucagon-like peptide 1(GLP1), gastric inhibitory peptide (GIP), cholecystokinin (CCK), amylin, peptide YY (PYY), oxyntomodulin, and leptin. Mechanical distention of the stomach elicits mechanoreceptors within the gastric wall sensing tension, stretch, and volume, which then send brain signals through vagal and spinal sensory nerves.

Both stomach and gut are tightly connected with the central nervous system where the fullness sensation is elaborated. Peripheral signaling hormones regulate appetite in the hypothalamic arcuate nucleus through anorexigenic and orexigenic signals. The gut–hindbrain axis is sufficient to drive the satiation sensation, although hindbrain also communicates with the forebrain where sensory and cognitive processes linked to meal anticipation and learned associations play a relevant role in the anticipation of food reward and pleasure.

We report an overview of the intestinal mechanisms regulating satiety and body weight with particular emphasis to the effects of drugs and bariatric/metabolic surgery on gut hormonal secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderberg RH, Richard JE, Eerola K, López-Ferreras L, Banke E, Hansson C, Nissbrandt H, Berqquist F, Gribble FM, Reimann F, Wernstedt Asterholm I, Lamy CM, Skibicka KP. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes. 2017;66:1062–73.

    Article  CAS  Google Scholar 

  • Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941–8.

    Article  CAS  Google Scholar 

  • Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med. 2006;12:917–24.

    Article  CAS  Google Scholar 

  • Bi S, Scott KA, Kopin AS, Moran TH. Differential roles for cholecystokinin a receptors in energy balance in rats and mice. Endocrinology. 2004;145:3873–80.

    Article  CAS  Google Scholar 

  • Brown JC, Pederson RA. A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin. Scand J Gastroenterol. 1970;5:537–41.

    CAS  PubMed  Google Scholar 

  • Brown JC, Mutt V, Pederson RA. Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol. 1970;209:57–64.

    Article  CAS  Google Scholar 

  • Brownley KA, Heymen S, Hinderliter AL, MacIntosh B. Effect of glycemic load on peptide-YY levels in a biracial sample of obese and normal weight women. Obesity. 2010;18:1297–303.

    Article  CAS  Google Scholar 

  • Clerc P, Coll Constans MG, Lulka H, Broussaud S, Guigné C, Leung-Theung-Long S, Perrin C, Knauf C, Carpéné C, Pénicaud L, Seva C, Burcelin R, Valet P, Fourmy D, Dufresne M. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology. 2007;148:1039–49.

    Article  CAS  Google Scholar 

  • Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.

    Article  Google Scholar 

  • De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, Rainteau D, Schneiter P, Tappy L, Giusti V. Long-term effects of roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabeticsubjects: a cross-sectional pilot study. Clin Nutr. 2015;34:911–7.

    Article  Google Scholar 

  • Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer EM, Olsen J, Sundler F, Christensen JP, Wierup N, Olsen JV, Holst JJ, Zigman JM, Poulsen SS, Schwartz TW. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153:5782–95.

    Article  CAS  Google Scholar 

  • Farr OM, Sofopoulos M, Tsoukas MA, Dincer F, Thakkar B, Sahin-Efe A, Filippaios A, Bowers J, Srnka A, Gavrieli A, Ko BJ, Liakou C, Kanyuch N, Tseleni-Balafouta S, Mantzoros CS. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia. 2016;59:954–65.

    Article  CAS  Google Scholar 

  • Gault VA, O’Harte FP, Harriott P, Flatt PR. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. Biochem Biophys Res Commun. 2002;290:1420–6.

    Article  CAS  Google Scholar 

  • Gebre-Medhin S, Mulder H, Pekny M, Westermark G, Törnell J, Westermark P, Sundler F, Ahrén B, Betsholtz C. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun. 1998;250:271–7.

    Article  CAS  Google Scholar 

  • Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature. 1973;245:3235.

    Article  Google Scholar 

  • de Heer J, Rasmussen C, Coy DH, Holst JJ. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia. 2008;51:2263–70.

    Article  CAS  Google Scholar 

  • Hill DR, Woodruff GN. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res. 1990;526:276–83.

    Article  CAS  Google Scholar 

  • Hill BR, De Souza MJ, Williams NI. Characterization of the diurnal rhythm of peptide YY and its association with energy balance parameters in normal-weight premenopausal women. Am J Physiol Endocrinol Metab. 2011;301:E409–15.

    Article  CAS  Google Scholar 

  • Hirasawa A, et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11:90–4.

    Article  CAS  Google Scholar 

  • Irving AD, Smith G, Coubrough H. Long-term metabolic effects of truncal vagotomy and gastrojejunostomy for chronic duodenal ulcer. Clin Nutr. 1985;4:129–33.

    Article  CAS  Google Scholar 

  • Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22:1084–96.

    Article  CAS  Google Scholar 

  • Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA. 2007;104:15069–74.

    Article  CAS  Google Scholar 

  • Jordan J, Greenway FL, Leiter LA, Li Z, Jacobson P, Murphy K, Hill J, Kler L, Aftring RP. Stimulation of cholecystokinin-a receptors with GI181771X does not cause weight loss in overweight or obese patients. Clin Pharmacol Ther. 2008;83:281–7.

    Article  CAS  Google Scholar 

  • Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987;2:1300–4.

    Article  CAS  Google Scholar 

  • Labelle M, Boulanger Y, Fournier A, St.-Pierre S, Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides. 1997;18:801–8.

    Article  CAS  Google Scholar 

  • Lieverse RJ, Jansen JB, Masclee AA, Lamers CB. Satiety effects of a physiological dose of cholecystokinin in humans. Gut. 1995;36:176–9.

    Article  CAS  Google Scholar 

  • Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015;161:999–1011.

    Article  CAS  Google Scholar 

  • Mace OJ, Affleck J, Patel N, Kellett GL. Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. J Physiol. 2007;582:379–92.

    Article  CAS  Google Scholar 

  • Mingrone G, Manco M, Granato L, Calvani M, Scarfone A, Mora EV, Greco AV, Vidal H, Castagneto M, Ferrannini E. Leptin pulsatility in formerly obese women. FASEB J. 2005;19:1380–2.

    Article  CAS  Google Scholar 

  • Mingrone G, Granato L, Valera-Mora E, Iaconelli A, Calvani MF, Bracaglia R, Manco M, Nanni G, Castagneto M. Ultradian ghrelin pulsatility is disrupted in morbidly obese subjects after weight loss induced by malabsorptive bariatric surgery. Am J Clin Nutr. 2006;83:1017–24.

    Article  CAS  Google Scholar 

  • Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8:738–42.

    Article  CAS  Google Scholar 

  • Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med. 2004;10:739–43.

    Article  CAS  Google Scholar 

  • Opie EL. Pathological changes affecting the islands of Langherans of the pancreas. J Boston Soc Med Sci. 1900;4:251–60.

    PubMed  PubMed Central  Google Scholar 

  • Pederson RA, Brown JC. The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology. 1976;99:780–5.

    Article  CAS  Google Scholar 

  • Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP, SCALE Obesity and Prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0 mg of Liraglutide in weight management. N Engl J Med. 2015;373:11–22.

    Article  Google Scholar 

  • Powley TL, Phillips RJ. Gastric satiation is volumetric, intestinal satiation is nutritive. Physiol Behav. 2004;82:69–74.

    Article  CAS  Google Scholar 

  • Reichmann F, Holzer P. Neuropeptide Y: A stressful review. Neuropeptides. 2016;55:99–109.

    Article  CAS  Google Scholar 

  • Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol Behav. 2004;81:249–73.

    Article  CAS  Google Scholar 

  • le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz RV, Wilding JP, Skjøth TV, Manning LS, Pi-Sunyer X, SCALE Obesity Prediabetes NN8022-1839 Study Group. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–409.

    Article  Google Scholar 

  • Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–42.

    Article  Google Scholar 

  • Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB, Billington CJ. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013;2013:245683.

    Article  CAS  Google Scholar 

  • Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM. Changes in GI hormones and their effect on gastric emptying and transit times after roux-en-Y gastric bypass in rat model. Surgery. 2005;138:283–90.

    Article  Google Scholar 

  • Takagi K, Legrand R, Asakawa A, Amitani H, François M, Tennoune N, Coëffier M, Claeyssens S, do Rego JC, Déchelotte P, Inui A, Fetissov SO. Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun. 2013;4:2685.

    Article  Google Scholar 

  • Takiguchi S, Takata Y, Funakoshi A, Miyasaka K, Kataoka K, Fujimura Y, Goto T. Kono a disrupted cholecystokinin type-a receptor (CCKAR) gene in OLETF rats. Gene. 1997;197:169–75.

    Article  CAS  Google Scholar 

  • Thon M, Hosoi T, Ozawa K. Possible integrative actions of leptin and insulin signaling in the hypothalamus targeting energy homeostasis. Front Endocrinol (Lausanne). 2016;7:138.

    Article  Google Scholar 

  • Wang G, Tomasi D, Backus W, Wang R, Telang F, Geliebter A, Korner J, Bauman A, Fowler JS, Thanos PK, Volkow ND. Gastric distention activates satiety circuitry in the human brain. NeuroImage. 2008;39:1824–31.

    Article  Google Scholar 

  • West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Phys. 1984;246:R776.

    CAS  Google Scholar 

  • Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795–26.

    Article  CAS  Google Scholar 

  • Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology. 2009;150:1680–7.

    Article  CAS  Google Scholar 

  • Wynne K, et al. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 2005;54:2390–5.

    Article  CAS  Google Scholar 

  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy

    Lidia Castagneto Gissey & James Casella Mariolo

  2. Department of Internal Medicine, Catholic University, Rome, Italy

    Geltrude Mingrone

  3. Diabetes and Nutritional Sciences, King’s College London, London, UK

    Geltrude Mingrone

Authors
  1. Lidia Castagneto Gissey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Casella Mariolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Geltrude Mingrone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geltrude Mingrone .

Editor information

Editors and Affiliations

  1. Department of Systems Medicine, Internal Medicine Unit and Obesity Center, University of Rome Tor Vergata, University Hospital Policlinico Tor Vergata, Rome, Italy

    Paolo Sbraccia

  2. National Centre for Cardiovascular Prevention, University College London, London, UK

    Nicholas Finer

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Castagneto Gissey, L., Casella Mariolo, J., Mingrone, G. (2019). Roles of Gut Hormones in the Regulation of Food Intake and Body Weight. In: Sbraccia, P., Finer, N. (eds) Obesity. Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-46933-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46933-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46932-4

  • Online ISBN: 978-3-319-46933-1

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation